Pro-Dex, Inc. (PDEX): Price and Financial Metrics

Pro-Dex, Inc. (PDEX): $16.21

0.26 (+1.63%)

POWR Rating

Component Grades













PDEX Stock Summary

  • With a market capitalization of $62,498,371, Pro Dex Inc has a greater market value than only 10.91% of US stocks.
  • Price to trailing twelve month operating cash flow for PDEX is currently 59.18, higher than 91.61% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of 25.68%, Pro Dex Inc's debt growth rate surpasses 76.54% of about US stocks.
  • Stocks that are quantitatively similar to PDEX, based on their financial statements, market capitalization, and price volatility, are GBT, CERS, SMTC, BLI, and VIVE.
  • Visit PDEX's SEC page to see the company's official filings. To visit the company's web site, go to

PDEX Valuation Summary

  • PDEX's price/sales ratio is 2.3; this is 79.74% lower than that of the median Healthcare stock.
  • PDEX's price/sales ratio has moved up 2 over the prior 243 months.
  • Over the past 243 months, PDEX's EV/EBIT ratio has gone up 7.4.

Below are key valuation metrics over time for PDEX.

Stock Date P/S P/B P/E EV/EBIT
PDEX 2021-08-31 2.3 4.5 15.0 12.9
PDEX 2021-08-30 2.4 4.6 15.3 13.1
PDEX 2021-08-27 2.4 4.7 15.6 13.4
PDEX 2021-08-26 2.8 5.5 18.2 15.4
PDEX 2021-08-25 2.9 5.6 18.7 15.8
PDEX 2021-08-24 2.9 5.6 18.6 15.7

PDEX Growth Metrics

    Its 5 year cash and equivalents growth rate is now at 201.52%.
  • Its year over year price growth rate is now at 72.56%.
  • The 4 year net cashflow from operations growth rate now stands at 284.52%.
Over the past 15 months, PDEX's revenue has gone up $5,152,000.

The table below shows PDEX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 41.335 1.056 4.837
2021-09-30 39.427 1.511 4.249
2021-06-30 38.029 -2.078 4.45
2021-03-31 39.718 -0.156 6.142
2020-12-31 36.487 3.472 5.36
2020-09-30 36.183 3.149 6.272

PDEX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PDEX has a Quality Grade of C, ranking ahead of 55.91% of graded US stocks.
  • PDEX's asset turnover comes in at 1.002 -- ranking 19th of 186 Medical Equipment stocks.
  • APEN, ZBH, and BDX are the stocks whose asset turnover ratios are most correlated with PDEX.

The table below shows PDEX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.002 0.357 0.150
2021-03-31 1.114 0.371 0.230
2020-12-31 1.136 0.372 0.237
2020-09-30 1.217 0.382 0.312
2020-06-30 1.201 0.377 0.316
2020-03-31 1.112 0.371 0.260

PDEX Price Target

For more insight on analysts targets of PDEX, see our PDEX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $39.00 Average Broker Recommendation 1.5 (Moderate Buy)

PDEX Stock Price Chart Interactive Chart >

Price chart for PDEX

PDEX Price/Volume Stats

Current price $16.21 52-week high $32.00
Prev. close $15.95 52-week low $12.40
Day low $15.56 Volume 4,629
Day high $16.25 Avg. volume 9,156
50-day MA $15.40 Dividend yield N/A
200-day MA $20.42 Market Cap 58.66M

Pro-Dex, Inc. (PDEX) Company Bio

Pro-Dex, Inc. products and distributes medical and dental equipment. The Company offers micro-air motors, surgical drivers, and precision air powered motors. Pro-Dex markets its products in the United States.

PDEX Latest News Stream

Event/Time News Detail
Loading, please wait...

PDEX Latest Social Stream

Loading social stream, please wait...

View Full PDEX Social Stream

Latest PDEX News From Around the Web

Below are the latest news stories about Pro Dex Inc that investors may wish to consider to help them evaluate PDEX as an investment opportunity.

What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Pro-Dex, Inc. ( NASDAQ:PDEX ), is not the largest company out there, but it received a lot of attention from a...

Yahoo | March 6, 2022

Pro-Dex, Inc. Discusses 2nd Quarter Sales and New Product Development with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - February 24, 2022) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. President and CEO of the Company, Rick Van Kirk, joined Stock Day host Everett Jolly. Jolly began the interview by asking about

Yahoo | February 24, 2022

Pro-Dex (NASDAQ:PDEX) shareholders have earned a 36% CAGR over the last five years

Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...

Yahoo | February 4, 2022

Pro-Dex, Inc. Announces Fiscal 2022 Second Quarter and Six-Month Results

IRVINE, CA / ACCESSWIRE / February 3, 2022 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2022 second quarter ended December 31, 2021.

Yahoo | February 3, 2022

Pro-Dex, Inc.'s (NASDAQ:PDEX) Stock Is Going Strong: Is the Market Following Fundamentals?

Most readers would already be aware that Pro-Dex's (NASDAQ:PDEX) stock increased significantly by 13% over the past...

Yahoo | January 5, 2022

Read More 'PDEX' Stories Here

PDEX Price Returns

1-mo 2.21%
3-mo 0.06%
6-mo -30.16%
1-year -48.21%
3-year 23.93%
5-year 163.58%
YTD -30.16%
2021 -25.06%
2020 76.47%
2019 45.28%
2018 77.65%
2017 44.68%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7678 seconds.